132 related articles for article (PubMed ID: 28551384)
21. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
[TBL] [Abstract][Full Text] [Related]
22. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
23. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
Bruhn MA; Townsend AR; Khoon Lee C; Shivasami A; Price TJ; Wrin J; Arentz G; Tebbutt NC; Hocking C; Cunningham D; Hardingham JE;
Int J Cancer; 2014 Aug; 135(3):731-41. PubMed ID: 24374727
[TBL] [Abstract][Full Text] [Related]
24. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
25. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
26. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
27. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
[TBL] [Abstract][Full Text] [Related]
28. CPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors.
Chen W; Hu Z; Li XZ; Li JL; Xu XK; Li HG; Liu Y; Liu BH; Jia WH; Li FC
Tumour Biol; 2016 Apr; 37(4):5075-87. PubMed ID: 26546435
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
30. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
31. Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancer.
Ljuslinder I; Melin B; Henriksson ML; Öberg Å; Palmqvist R
Int J Cancer; 2011 May; 128(9):2031-7. PubMed ID: 20635387
[TBL] [Abstract][Full Text] [Related]
32. Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer.
Pedrazzani C; Mantovani G; Salvagno GL; Baldiotti E; Ruzzenente A; Iacono C; Lippi G; Guglielmi A
World J Gastroenterol; 2016 Dec; 22(45):9994-10001. PubMed ID: 28018106
[TBL] [Abstract][Full Text] [Related]
33. Liver metastases from colorectal cancer: present surgical approach.
Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
[TBL] [Abstract][Full Text] [Related]
34. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-203-mediated posttranscriptional deregulation of CPEB4 contributes to colorectal cancer progression.
Zhong X; Xiao Y; Chen C; Wei X; Hu C; Ling X; Liu X
Biochem Biophys Res Commun; 2015 Oct; 466(2):206-13. PubMed ID: 26361147
[TBL] [Abstract][Full Text] [Related]
36. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
[TBL] [Abstract][Full Text] [Related]
38. Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
Calderone V; Gallego J; Fernandez-Miranda G; Garcia-Pras E; Maillo C; Berzigotti A; Mejias M; Bava FA; Angulo-Urarte A; Graupera M; Navarro P; Bosch J; Fernandez M; Mendez R
Gastroenterology; 2016 Apr; 150(4):982-97.e30. PubMed ID: 26627607
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]